News | Clinical Trials | July 19, 2018

A new study in the Journal of the National Cancer Institute suggests that CT scans, commonly used in medical imaging, may increase the risk of brain tumors.

computed tomography brain scan

Image courtesy of Pixabay


The use of computed tomography (CT) scans has increased dramatically over the last two decades. CT scans greatly improve diagnostic capabilities (which improve clinical outcomes) but they deliver higher radiation doses than other tests. Therefore, radiation protection is a concern, especially among children, who may receive higher radiation doses, are more susceptible to radiation-related malignancies than adults and have more time to show effects from the potential risk.

The most common malignancies caused by radioactivity among children and young adults are leukemia and brain tumors. Researchers therefore evaluated leukemia and brain tumor risks following exposure to radiation from CT scans in childhood.

For a nationwide group of 168,394 Dutch children who received one or more CT scans between 1979 and 2012, researchers obtained cancer incidence and vital status by record linkage. They surveyed all Dutch hospital-based radiology departments to ascertain eligibility and participation. In the Netherlands, pediatric CT scans are only performed in hospitals.

Overall cancer incidence was 1.5 times higher than expected. For all brain tumors combined, and for malignant and nonmalignant brain tumors separately, dose-response relationships were observed with radiation dose to the brain. Relative risks increased to between two and four for the highest dose category. The researchers observed no association for leukemia. Radiation doses to the bone marrow, where leukemia originates, were low.

The researchers caution that this pattern of excess cancer risk may be partly due to confounding by indication, because the incidence of brain tumors was higher in the cohort than in the general population. CT scans are sometimes used to identify conditions associated with an increased tumor risk; the reason these children had CT scans may be associated with their risk of developing cancer.

"Epidemiological studies of cancer risks from low doses of medical radiation are challenging, said the study's principal investigator, Michael Hauptmann. "Nevertheless, our careful evaluation of the data and evidence from other studies indicate that CT-related radiation exposure increases brain tumor risk. Careful justification of pediatric CT scans and dose optimization, as done in many hospitals, are essential to minimize risks."


Related Content

News | Ultrasound Imaging

June 3, 2025 — In a collaborative study between the Departments of Radiology at the Children’s Hospital of Philadelphia ...

Time June 04, 2025
arrow
News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Computed Tomography (CT)

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...

Time December 18, 2024
arrow
News | SPECT Imaging

Dec. 2, 2024 — GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing ...

Time December 05, 2024
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Subscribe Now